fenfluramine epilepsy Fintepla
Selected indexed studies
- Recent advances in pharmacotherapy for epilepsy. (Curr Opin Neurol, 2023) [PMID:36762638]
- International consensus on diagnosis and management of Dravet syndrome. (Epilepsia, 2022) [PMID:35490361]
- Dravet syndrome. (Curr Opin Neurol, 2021) [PMID:33395108]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical Trial. (2022) pubmed
- Refining management strategies for Lennox-Gastaut syndrome: Updated algorithms and practical approaches. (2025) pubmed
- Fenfluramine (Fintepla) for Dravet syndrome. (2021) pubmed
- Dravet syndrome. (2021) pubmed
- International consensus on diagnosis and management of Dravet syndrome. (2022) pubmed
- Recent advances in pharmacotherapy for epilepsy. (2023) pubmed
- Update on Antiseizure Medications 2022. (2022) pubmed
- Genetic Background of Epilepsy and Antiepileptic Treatments. (2023) pubmed
- The epilepsy-autism phenotype associated with developmental and epileptic encephalopathies: New mechanism-based therapeutic options. (2025) pubmed
- Dravet syndrome: Advances in etiology, clinical presentation, and treatment. (2022) pubmed